U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07333716) titled 'Desloratadine in Patients With Ulcerative Colitis' on Jan. 01.
Brief Summary: The purpose of this study is to investigate safety and therapeutic efficacy of antihistamine (desloratadine) on inflammation and disease activity when administered as adjuvant therapies with the traditional therapy 5-aminosalisylic acid (mesalamine) in patients with mild to moderate ulcerative colitis.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Ulcerative Colitis (UC)
Ulcerative Colitis
Intervention:
DRUG: Desloratadine
mesalamine 1000 mg three times daily plus desloratadine 5 mg once daily for 3 months.
DRUG: mesalamine
me...